Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,902 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders.
Marklund E, Leach S, Axelsson H, Nyström K, Norder H, Bemark M, Angeletti D, Lundgren A, Nilsson S, Andersson LM, Yilmaz A, Lindh M, Liljeqvist JÅ, Gisslén M. Marklund E, et al. Among authors: nilsson s. PLoS One. 2020 Oct 21;15(10):e0241104. doi: 10.1371/journal.pone.0241104. eCollection 2020. PLoS One. 2020. PMID: 33085715 Free PMC article.
Serum neopterin levels in relation to mild and severe COVID-19.
Robertson J, Gostner JM, Nilsson S, Andersson LM, Fuchs D, Gisslen M. Robertson J, et al. Among authors: nilsson s. BMC Infect Dis. 2020 Dec 10;20(1):942. doi: 10.1186/s12879-020-05671-7. BMC Infect Dis. 2020. PMID: 33302893 Free PMC article.
No effect of remdesivir or betamethasone on upper respiratory tract SARS-CoV-2 RNA kinetics in hospitalised COVID-19 patients: a retrospective observational study.
Sourander B, Andersson LM, Brink M, Yilmaz A, Sundell N, Marklund E, Nilsson S, Lindh M, Robertson J, Gisslén M. Sourander B, et al. Among authors: nilsson s. Infect Dis (Lond). 2022 Oct;54(10):703-712. doi: 10.1080/23744235.2022.2081716. Epub 2022 Jun 16. Infect Dis (Lond). 2022. PMID: 35708280
Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naïve HIV-1-infected individuals over 144 weeks: an open-label randomized controlled trial.
Andersson LM, Vesterbacka J, Blaxhult A, Flamholc L, Nilsson S, Ormaasen V, Sönnerborg A, Gisslén M. Andersson LM, et al. Among authors: nilsson s. Scand J Infect Dis. 2013 Jul;45(7):543-51. doi: 10.3109/00365548.2012.756985. Epub 2013 Jan 7. Scand J Infect Dis. 2013. PMID: 23294034 Clinical Trial.
1,902 results